2-(2,4-Dioxo-5-(2,3,6-trichlorobenzylidene)thiazolidin-3-yl)-N-(4-methylpiperazin-1-yl)acetamide

ID: ALA4129450

PubChem CID: 145963279

Max Phase: Preclinical

Molecular Formula: C17H17Cl3N4O3S

Molecular Weight: 463.77

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CN1CCN(NC(=O)CN2C(=O)S/C(=C\c3c(Cl)ccc(Cl)c3Cl)C2=O)CC1

Standard InChI:  InChI=1S/C17H17Cl3N4O3S/c1-22-4-6-23(7-5-22)21-14(25)9-24-16(26)13(28-17(24)27)8-10-11(18)2-3-12(19)15(10)20/h2-3,8H,4-7,9H2,1H3,(H,21,25)/b13-8-

Standard InChI Key:  HGSYUTHQDDLTJN-JYRVWZFOSA-N

Molfile:  

     RDKit          2D

 28 30  0  0  0  0  0  0  0  0999 V2000
    5.9916   -6.4834    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    6.8166   -6.4834    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0735   -5.6993    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.4041   -5.2125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7391   -5.6993    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4029   -4.3875    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.3008   -7.1514    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9544   -5.4446    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3415   -5.9970    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8584   -5.4453    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0310   -4.6386    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8161   -4.3848    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.4187   -4.0858    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.9887   -3.5781    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.7724   -3.3281    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9462   -2.5253    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3365   -1.9690    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.5499   -2.2212    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3732   -3.0298    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5121   -1.1629    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5577   -5.7399    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9451   -6.2915    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1168   -7.0993    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9064   -7.3526    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5155   -6.7994    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3873   -4.9327    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    2.1605   -6.0365    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    5.3012   -7.0510    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  1  1  0
  4  6  2  0
  2  7  2  0
  5  8  2  0
  8  9  1  0
  3 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  2  0
 12 14  1  0
 14 15  1  0
 14 19  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 17 20  1  0
  9 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25  9  1  0
 21 26  1  0
 22 27  1  0
 25 28  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4129450

    ---

Associated Targets(non-human)

blm Metallo-beta-lactamase type 2 (65 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 463.77Molecular Weight (Monoisotopic): 462.0087AlogP: 2.96#Rotatable Bonds: 4
Polar Surface Area: 72.96Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 10.84CX Basic pKa: 6.97CX LogP: 2.27CX LogD: 2.14
Aromatic Rings: 1Heavy Atoms: 28QED Weighted: 0.55Np Likeness Score: -1.79

References

1. Zhang D, Markoulides MS, Stepanovs D, Rydzik AM, El-Hussein A, Bon C, Kamps JJAG, Umland KD, Collins PM, Cahill ST, Wang DY, von Delft F, Brem J, McDonough MA, Schofield CJ..  (2018)  Structure activity relationship studies on rhodanines and derived enethiol inhibitors of metallo-β-lactamases.,  26  (11): [PMID:29655609] [10.1016/j.bmc.2018.02.043]

Source